Skip to main content

Table 1 Baseline characteristics of the study participants

From: The effects of Taurine supplementation on inflammatory markers and clinical outcomes in patients with traumatic brain injury: a double-blind randomized controlled trial

Variable Taurine (n = 22) Control (n = 22) p-value
Age (year) 33.3 ± 13.4 32.4 ± 11.4 0.80
Gender (N [%])    0.99
 Male 17 (77.3) 18 (81.8)  
 Female 5 (22.7) 4 (18.2)  
Weight (kg) 74.1 ± 11.72 74.3 ± 8.61 0.96
BMI (kg/ m2) 25.3 ± 3.2 25.2 ± 2.5 0.85
Cause of TBI (N [%])    0.51
 Accident 20 (90.9) 20 (90.9)  
 Fall 1 (4.5) 2 (9.1)  
 Gun shut 1 (4.5) 0 (0)  
Glasgow Coma Scale 7 (7, 7) 7 (7, 8) 0.07
Type of TBI based on CT scan findings (N [%])    0.79
 Diffuse axonal injury 12 (54.5) 12 (54.5)  
 Extradural hemorrhage 3 (13.6) 2 (9.1)  
 Subarachnoid hemorrhage 2 (9.1) 3 (13.6)  
 Subdural hematoma 4 (18.2) 4 (18.2)  
 Intraventricular hemorrhage 0 (0) 1 (4.5)  
 Intracerebral hemorrhage 1 (4.5) 0 (0)  
Surgical procedures    0.99
 Craniotomy 10 (45.5) 10 (45.5)  
Temperature (°C) 37.3 ± 0.7 37.3 ± 0.9 0.93
Mean Arterial Pressure (mmHg) 92 ± 13.6 93.6 ± 11.8 0.68
APACHEII score 14 (12, 16) 14 (11, 16) 0.80
SOFA score 8 (6, 9) 8 (7, 9) 0.25
  1. The Fisher’s exact test was used for gender, the Pearson chi-square test for cause of TBI, type of TBI and surgical procedures, Mann-Whitney U test for GCS, APACHEII and SOFA scores, and independent samples t-test for the others. Values are presented as mean ± SD, median (IQR), or frequency (percent).